Literature DB >> 10825027

Pneumonia in the elderly: overview of diagnostic and therapeutic approaches.

A M Fein1.   

Abstract

Pneumonia is more frequent in the elderly and results in higher morbidity and mortality. Although the incidence of pneumonia increases with age, from 1 per 1,000 to 12 per 1,000 persons over age 75 years, comorbid medical illnesses and host defense impairments (especially heart disease, chronic obstructive pulmonary disease, and aspiration risk) are independent risk factors. The microbial etiology of pneumonia in the healthy elderly is similar to that in younger patients but shifts toward a more gram-negative and opportunistic flora with increasing age and severity of concomitant medical illness. The choice of antimicrobial therapy must be based on risk stratification (age, medical illnesses, and severity of presentation). Guidelines based on these principles will be reviewed. Pneumococcal and influenza vaccination reduce the risk of death due to pneumonia and are cost-effective preventative strategies.

Entities:  

Mesh:

Year:  1999        PMID: 10825027     DOI: 10.1086/515218

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Monocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection.

Authors:  Gayathriy Balamayooran; Sanjay Batra; Theivanthiran Balamayooran; Shanshan Cai; Samithamby Jeyaseelan
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice.

Authors:  Sanjay Batra; Shanshan Cai; Gayathriy Balamayooran; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

3.  Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection.

Authors:  Shanshan Cai; Sanjay Batra; Li Shen; Nobuko Wakamatsu; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

4.  Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics.

Authors:  L P Jetté; G Delage; L Ringuette; R Allard; P De Wals ; F Lamothe; V Loo
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Age thresholds for increased mortality of predominant crash induced thoracic injuries.

Authors:  Joel D Stitzel; Patrick D Kilgo; Ashley A Weaver; R Shayn Martin; Kathryn L Loftis; J Wayne Meredith
Journal:  Ann Adv Automot Med       Date:  2010

6.  Infections in the older population: what do we know?

Authors:  Didier Schoevaerdts; François-Xavier Sibille; Gaetan Gavazzi
Journal:  Aging Clin Exp Res       Date:  2019-10-26       Impact factor: 3.636

Review 7.  Nursing home-acquired pneumonia: update on treatment options.

Authors:  Joseph M Mylotte
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

8.  Reduced mucociliary clearance in old mice is associated with a decrease in Muc5b mucin.

Authors:  Barbara R Grubb; Alessandra Livraghi-Butrico; Troy D Rogers; Weining Yin; Brian Button; Lawrence E Ostrowski
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-03-11       Impact factor: 5.464

Review 9.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses.

Authors:  A Rial; D Lens; L Betancor; H Benkiel; J S Silva; J A Chabalgoity
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.